NO903532L - Fremgangsmaate for behandling av kardiell, saavel som vaskulaer hypertropi og hyperplasi. - Google Patents
Fremgangsmaate for behandling av kardiell, saavel som vaskulaer hypertropi og hyperplasi.Info
- Publication number
- NO903532L NO903532L NO90903532A NO903532A NO903532L NO 903532 L NO903532 L NO 903532L NO 90903532 A NO90903532 A NO 90903532A NO 903532 A NO903532 A NO 903532A NO 903532 L NO903532 L NO 903532L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- administration
- vasculas
- hyperplasy
- cardially
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Preliminary Treatment Of Fibers (AREA)
- Crucibles And Fluidized-Bed Furnaces (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Element Separation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3926606A DE3926606A1 (de) | 1989-08-11 | 1989-08-11 | Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie |
Publications (3)
Publication Number | Publication Date |
---|---|
NO903532D0 NO903532D0 (no) | 1990-08-10 |
NO903532L true NO903532L (no) | 1991-02-12 |
NO306979B1 NO306979B1 (no) | 2000-01-24 |
Family
ID=6386970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO903532A NO306979B1 (no) | 1989-08-11 | 1990-08-10 | Fremgangsmåte for fremstilling av et farmasoeytisk preparat for behandling av kardial så vel som vaskulaer hypertrofi og hyperplasi |
Country Status (22)
Country | Link |
---|---|
US (1) | US5231083A (no) |
EP (1) | EP0417473B1 (no) |
JP (1) | JP3452199B2 (no) |
KR (1) | KR0185969B1 (no) |
AT (1) | ATE94409T1 (no) |
AU (1) | AU631914B2 (no) |
CA (1) | CA2023089C (no) |
CS (1) | CS277644B6 (no) |
DD (1) | DD297063A5 (no) |
DE (2) | DE3926606A1 (no) |
DK (1) | DK0417473T3 (no) |
ES (1) | ES2059931T3 (no) |
FI (1) | FI903936A0 (no) |
HU (1) | HU205008B (no) |
IE (1) | IE64604B1 (no) |
IL (1) | IL95327A (no) |
NO (1) | NO306979B1 (no) |
NZ (1) | NZ234836A (no) |
PH (1) | PH30831A (no) |
PL (1) | PL286442A1 (no) |
PT (1) | PT94957B (no) |
ZA (1) | ZA906327B (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0682947B1 (en) | 1994-05-19 | 1997-09-10 | Mitsubishi Chemical Corporation | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia |
SG68529A1 (en) * | 1995-05-25 | 1999-11-16 | Univ Singapore | The use of des-aspartate-angiotensin i (agr-val-tyr-ile-his-pro-phe-his-leu) as an anti-cardiac hypertrophic agent |
SE9903028D0 (sv) * | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
RS50377B (sr) * | 1999-08-30 | 2009-11-10 | Sanofi-Aventis Deutschland Gmbh., | Inhibitori sistema renin-angiotenzin i njihova primena |
US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
ZA200704768B (en) * | 2004-11-05 | 2008-08-27 | King Pharmaceuticals Res & Dev | Stabilized ramipril compositions and methods of making |
WO2012071369A2 (en) | 2010-11-24 | 2012-05-31 | The Trustees Of Columbia University In The City Of New York | A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease |
WO2013166037A1 (en) | 2012-05-01 | 2013-11-07 | The Trustees Of Columbia University In The City Of New York | Non-retinoid antagonists for treatment of eye disorders |
EP2968303B1 (en) | 2013-03-14 | 2018-07-04 | The Trustees of Columbia University in the City of New York | Octahydrocyclopentapyrroles, their preparation and use |
WO2014151959A1 (en) | 2013-03-14 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | N-alkyl-2-phenoxyethanamines, their preparation and use |
ES2705247T3 (es) | 2013-03-14 | 2019-03-22 | Univ Columbia | 4-fenilpiperidinas, su preparación y uso |
US9944644B2 (en) | 2013-03-14 | 2018-04-17 | The Trustees Of Columbia University In The City Of New York | Octahydropyrrolopyrroles their preparation and use |
ES2909793T3 (es) | 2014-04-30 | 2022-05-10 | Univ Columbia | 4-fenilpiperidinas sustituidas, su preparación y uso |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
US4311705A (en) * | 1980-10-06 | 1982-01-19 | E. R. Squibb & Sons, Inc. | Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines |
US4337201A (en) * | 1980-12-04 | 1982-06-29 | E. R. Squibb & Sons, Inc. | Phosphinylalkanoyl substituted prolines |
US4381297A (en) * | 1981-05-04 | 1983-04-26 | E. R. Squibb & Sons, Inc. | Substituted carbonyl phosphinyl-alkanoyl compounds |
US4602002A (en) * | 1983-02-07 | 1986-07-22 | Merck & Co., Inc. | N-carboxymethyl substituted lysyl and α-(ε-aminoalkyl) glycyl amino acid antihypertensive agents |
US4548941A (en) * | 1984-07-30 | 1985-10-22 | Merck & Co., Inc. | 1,5-Methano-1H-4-benzazonine dicarboxylates, process for preparing and use as calcium blockers |
US4587253A (en) * | 1984-07-30 | 1986-05-06 | Merck & Co., Inc. | Bridged pyridine compounds useful as calcium channel blockers and analgesics |
US4599341A (en) * | 1984-10-01 | 1986-07-08 | Merck & Co., Inc. | Substituted and bridged pyridines useful as calcium channel blockers |
US4656188A (en) * | 1985-10-09 | 1987-04-07 | Merck & Co., Inc. | Ace inhibitors in macular degeneration |
DE3705220A1 (de) * | 1987-02-19 | 1988-09-01 | Boehringer Ingelheim Kg | Mittel zur behandlung von coronarerkrankungen oder organischem hirnsyndrom |
ZA896851B (en) * | 1988-09-14 | 1990-06-27 | Hoffmann La Roche | Use of ace-inhibitors |
-
1989
- 1989-08-11 DE DE3926606A patent/DE3926606A1/de not_active Withdrawn
-
1990
- 1990-08-08 ES ES90115230T patent/ES2059931T3/es not_active Expired - Lifetime
- 1990-08-08 EP EP90115230A patent/EP0417473B1/de not_active Expired - Lifetime
- 1990-08-08 DE DE90115230T patent/DE59002721D1/de not_active Expired - Lifetime
- 1990-08-08 DK DK90115230.6T patent/DK0417473T3/da active
- 1990-08-08 AT AT90115230T patent/ATE94409T1/de not_active IP Right Cessation
- 1990-08-09 DD DD90343366A patent/DD297063A5/de unknown
- 1990-08-09 PT PT94957A patent/PT94957B/pt not_active IP Right Cessation
- 1990-08-09 IL IL9532790A patent/IL95327A/en unknown
- 1990-08-09 NZ NZ234836A patent/NZ234836A/en unknown
- 1990-08-09 FI FI903936A patent/FI903936A0/fi not_active Application Discontinuation
- 1990-08-09 US US07/564,618 patent/US5231083A/en not_active Expired - Lifetime
- 1990-08-09 PH PH41000A patent/PH30831A/en unknown
- 1990-08-10 JP JP21056490A patent/JP3452199B2/ja not_active Expired - Lifetime
- 1990-08-10 PL PL28644290A patent/PL286442A1/xx unknown
- 1990-08-10 KR KR1019900012267A patent/KR0185969B1/ko not_active IP Right Cessation
- 1990-08-10 ZA ZA906327A patent/ZA906327B/xx unknown
- 1990-08-10 IE IE291090A patent/IE64604B1/en not_active IP Right Cessation
- 1990-08-10 AU AU60920/90A patent/AU631914B2/en not_active Expired
- 1990-08-10 CS CS903958A patent/CS277644B6/cs not_active IP Right Cessation
- 1990-08-10 NO NO903532A patent/NO306979B1/no not_active IP Right Cessation
- 1990-08-10 CA CA002023089A patent/CA2023089C/en not_active Expired - Lifetime
- 1990-08-10 HU HU904966A patent/HU205008B/hu unknown
Also Published As
Publication number | Publication date |
---|---|
HU904966D0 (en) | 1991-01-28 |
PH30831A (en) | 1997-10-17 |
FI903936A0 (fi) | 1990-08-09 |
PT94957A (pt) | 1991-05-22 |
US5231083A (en) | 1993-07-27 |
DE3926606A1 (de) | 1991-02-14 |
DE59002721D1 (de) | 1993-10-21 |
HUT54504A (en) | 1991-03-28 |
PT94957B (pt) | 1997-05-28 |
IE902910A1 (en) | 1991-02-27 |
CA2023089C (en) | 2003-01-14 |
AU6092090A (en) | 1991-02-14 |
KR0185969B1 (ko) | 1999-05-01 |
ZA906327B (en) | 1991-05-29 |
JPH0383957A (ja) | 1991-04-09 |
ES2059931T3 (es) | 1994-11-16 |
AU631914B2 (en) | 1992-12-10 |
DD297063A5 (de) | 1992-01-02 |
EP0417473B1 (de) | 1993-09-15 |
PL286442A1 (en) | 1992-03-09 |
NZ234836A (en) | 1997-05-26 |
NO306979B1 (no) | 2000-01-24 |
JP3452199B2 (ja) | 2003-09-29 |
CA2023089A1 (en) | 1991-02-12 |
HU205008B (en) | 1992-03-30 |
CS277644B6 (en) | 1993-03-17 |
DK0417473T3 (da) | 1993-12-13 |
ATE94409T1 (de) | 1993-10-15 |
IL95327A (en) | 1995-10-31 |
CS395890A3 (en) | 1992-08-12 |
EP0417473A1 (de) | 1991-03-20 |
KR910004189A (ko) | 1991-03-28 |
NO903532D0 (no) | 1990-08-10 |
IL95327A0 (en) | 1991-06-30 |
IE64604B1 (en) | 1995-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR002012A1 (es) | Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto. | |
NO903532D0 (no) | Fremgangsmaate for behandling av kardiell, saavel som vaskulaer hypertropi og hyperplasi. | |
SE8503680D0 (sv) | Indolderivat | |
FI913478A0 (fi) | Diazinderivat. | |
DK490486D0 (da) | Sammensaetning til behandling af atherosclerose, tromboser og/eller perifere karsygdomme | |
NO165921C (no) | Fremgangsmaate for fremstilling av disubstituerte prolinderivater. | |
NO952205L (no) | Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter | |
ES2098023T3 (es) | Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen. | |
MX9400253A (es) | Derivados de piperazina, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
NO891703D0 (no) | Farmasoeytiske sammensetninger for behandling av psoriasis. | |
NZ217418A (en) | Tricyclic heterocyclic compounds and pharmaceutical compositions | |
DK0429370T3 (da) | Hiditl ukendte thiophenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
NO169176C (no) | Tyroninderivater, og deres fremstillig og anvendelse | |
EA199900684A1 (ru) | Производные иминоазаантрациклинона для лечения амилоидоза | |
ES2040750T3 (es) | Un procedimiento para la preparacion de un derivado de isoquinolinol. | |
NO880405D0 (no) | Fremgangsmaate til fremstilling av 3-fenyl-7h-tiazolo-/3,2-b//1,2,4/-tiazine-7-oner. | |
DK0635491T3 (da) | (Thia)cycloalkylab indoler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse forbindelser. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |